[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_2367 

# __Invasive individual testing__

## Property: has_RiskType

* [health](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_4.md)

## People affected by this risk

* [general population](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_9.md)
* [individuals with symptoms or high-risk exposures](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_1575.md)

## Name of the risk

Decreased willingness to get tested, leading to underreporting of cases and limited knowledge of the true prevalence of the virus.

## Property: has_RiskISO_Purpose

* [Well-being](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_1.md)

## Closest similar item

* [Mass testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_335.md)
* [Testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3453.md)
* [Limited testing and treatment capabilities](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2826.md)
* [Limited diagnostic and screening tests](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2185.md)
* [Screening](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3451.md)
* [Limited diagnostic tests](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2604.md)
* [Limited access to testing](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2366.md)
* [Limited testing access](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_881.md)
* [Low testing frequency in previously infected individuals](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_864.md)
* [Safety of laboratory personnel and environment during sample handling and analysis](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1628.md)

## Description of the risk

Individual testing methods for COVID-19 require invasive procedures such as nasopharyngeal swabs, which can be uncomfortable and inconvenient.

## Technologies linked to the risk

* [development of non-invasive testing techniques](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1972.md)
* [improvement of testing accuracy and reliability](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1973.md)

## Property: has_RiskHealth

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Mitigations of this risk

* [Develop and promote non-invasive testing methods, such as saliva or wastewater-based surveillance, to increase testing uptake.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3074.md)

## Articles mentionning the risk

* [SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_251.md)

## Property: has_RiskISO_Impact

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Property: has_RiskGBN

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Stakeholders who can mitigate this risk

* [healthcare systems](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_193.md)
* [public health officials](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_310.md)

